Adult outpatients with chronic and/or recurrent MDD were randomly assigned in @:@:@ ratio to @ weeks of single-blind , placebo-controlled antidepressant treatment with ( @ ) escitalopram + placebo , ( @ ) bupropion-sustained-release + escitalopram , or ( @ ) venlafaxine-extended-release + mirtazapine .